Medication-induced intracranial hypertension in dermatology

American Journal of Clinical Dermatology

Volumn 6, Issue 1, 2005, Pages 29-37

  Friedman, Deborah J ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b Box 659 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; DOXYCYCLINE; ETRETIN; ETRETINATE; GROWTH HORMONE; ISOTRETINOIN; LEUPRORELIN; LEVONORGESTREL; LEVOTHYROXINE SODIUM; LITHIUM; MINOCYCLINE; NALIDIXIC ACID; RETINOIC ACID; RETINOID; RETINOL; SULFANILAMIDE DERIVATIVE; TETRACYCLINE; TETRACYCLINE DERIVATIVE;

ACNE VULGARIS; ANTERIOR EYE SEGMENT; BRAIN PSEUDOTUMOR; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DRUG INDUCED DISEASE; DRY EYE; EARLY DIAGNOSIS; EYE INFLAMMATION; HEADACHE; HUMAN; IDIOPATHIC DISEASE; INTRACRANIAL HYPERTENSION; LUMBAR PUNCTURE; OPHTHALMOSCOPE; PAPILLEDEMA; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SKIN DISEASE; SYMPTOM; VISUAL DISORDER;

ADRENAL CORTEX HORMONES; ANTI-BACTERIAL AGENTS; CONTRACEPTIVES, ORAL, HORMONAL; DERMATOLOGY; HUMANS; INTRACRANIAL HYPERTENSION; OBESITY; PSEUDOTUMOR CEREBRI; RETINOIDS; TETRACYCLINES;

EID: 14244252903     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200506010-00004     Document Type: Review

References (89)

1. Ireland B, Corbett JJ. The search for causes of idiopathic intracranial hypertension. Arch Neurol 1990; 47: 315-20
2. Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri: population studies in Iowa and Louisiana. Arch Neurol 1988; 45: 875-7
3. Garrett JH, Corbett JJ, Braswell R. The incidence of idiopathic intracranial hypertension in Mississippi. Orlando (FL): North American Neuro-Ophthalmology Society, 2004: 269
4. Jacobs DA, Corbett JJ, Balcer LJ. Annual indicence of idiopathic intracranial hypertension (IIH) in the Philadelphia area. Orlando (FL): North American Neuro-Ophthalmology Society, 2004: 286
5. Corbett JJ, Savino PJ, Thompson HS, et al. Visual loss in pseudotumor cerebri: follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol 1982; 39: 461-74
6. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002; 59: 1492-5
7. Brodsky MC, Vaphiades M. Magnetic resonance imaging in pseudotumor cerebri. Ophthalmology 1998; 105: 1686-93
8. Biousse V, Ameri A, Bousser MG. Isolated intracranial hypertension as the only sign of cerebral venous thrombosis. Neurology 1999; 53: 1537-42
9. Friedman DI. Papilledema and pseudotumor cerebri. Neurol Clin 2001; 14 (1): 129-47
10. Selhorst JB, Kulkanthrakorn K, Corbett JJ, et al. Retinol-binding protein in idiopathic intracranial hypertension (UH). J Neuroophthalmol 2000; 20 (4): 250-2
11. Warner JEA, Bernstein PS, Yemelyanov A, et al. Vitamin A in the cerebrospinal fluid of patients with and without idiopathic intracranial hypertension. Ann Neurol 2002; 52: 647-50
12. Giuseffi V, Wall M, Spiegel PZ, et al. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology 1991; 41: 239-44
13. Wall M, George D. Idiopathic intracranial hypertension: a prospective study of 50 patients. Brain 1991; 114: 155-80
14. Rush JA. Pseudotumor cerebri: clinical profile and visual outcome in 63 patients. Mayo Clin Proc 1980; 55: 541-6
15. Round R, Keane JR. The minor symptoms of increased intracranial pressure: 101 patients with benign intracranial hypertension. Neurology 1988; 38: 1461-4
16. Wang SJ, Silberstein SD, Patterson S, et al. Idiopathic intracranial hypertension without papilledema: a case-control study in a headache center. Neurology 1998; 51: 245-9
17. Rodahl K. Moore T. The vitamin A content and toxicity of polar bear and seal liver. Biochem J 1943; 37: 166-9
18. DiGiovanna JJ. Systemic retinoid therapy. Dermatol Clin 1991; 19 (1): 161-7
19. Morrice Jr G, Havener WH, Kapetansky F. Vitamin A intoxication as a cause of pseudotumor cerebri. JAMA 1960; 173 (16): 1802-5
20. Dicken C, Connolly S. Systemic retinoids in dermatology. Mayo Clin Proc 1982; 57: 51-7
21. Lebowitz MA, Berson DS. Ocular effects of oral retinoids. J Am Acad Dermatol 1988; 19: 209-11
22. Lombaert A, Carton H. Benign intracranial hypertension due to A-hypervitaminosis in adults and adolescents. Eur Neurol 1976; 14: 340-50
23. Marie J, See G. Acute hypervitaminosis A of the infant: its clinical manifestation with benign acute hydrocephaly and pronounced bulge of the fontanel: a clinical and biologic study. Am J Dis Child 1954; 73: 731-6
24. Gerber AR. Vitamin A poisoning in adults: with a description of a case. Am J Med 1954; 16: 729-45
25. Restak RM. Pseudotumor cerebri, psychosis, and hypervitaminosis A. J Nerv Ment Dis 1972; 155: 72-5
26. Delaney RA. Narayanaswamy TR, Wee D. Pseudo-tumor cerebri and acne. Mil Med 1990; 155(10): 511
27. Feldman MH, Schlezinger NS. Benign intracranial hypertension associated with hypervitaminosis A. Arch Neurol 1970; 22: 1-7
28. Gangemi M, Maiuri F, DiMartino L, et al. Intracranial hypertension due to vitamin A intoxication. Acta Neurol (Napoli) 1985; 7 (1): 27-31
29. Krausz MM, Feinsod M, Beller AJ. Bilateral transverse sinus obstruction in benign intracranial hypertension due to hypervitaminosis A. Isr J Med Sci 1978; 14: 858-61
30. Josephs HW. Hypervitaminosis A and carotenemia. Am J Dis Child 1944; 67: 33-43
31. Misbah SA, Peins JB, Atukorala TM. Ingestion of shark liver associated with pseudotumor cerebri due to acute hypervitaminosis A. J Neurol Neurosurg Psychiatry 1984; 47 (2): 216
32. Amrani Y, Terriza F, Moreno C, et al. Pseudotumor cerebri caused by vitamin A excess due to intake of milk enriched with A and D vitamins. Rev Neurol 1996; 24 (134): 1304-5
33. Donahue SP. Recurrence of idiopathic intracranial hypertension after weight loss; the carrot craver. Am J Ophthalmol 2000; 130: 850-1
34. Selhorst JB, Waybright EA, Jennings S, et al. Liver lover's headache; pseudotumor cerebri and vitamin A intoxication [letter]. JAMA 1984; 252 (24): 3364
35. Food and Nutrition Board, Institute of Medicine. Dietary reference intakes of vitamin A, vitamin K, arsenic, boron, chromium, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium and zinc. Washington, DC: National Academy Press, 2002: 82-161
36. Pasquariello Jr PS, Schut L, Borns P. Benign increased intracranial hypertension due to chronic vitamin A overdosage in a 26-month-old child. Clin Pediatr 1977; 16: 379-82
37. Farris WE, Erdman Jr JW. Protracted hypervitaminosis A following long-term, low-level intake. JAMA 1982; 247 (9): 1317-8
38. Baqui AH, de Francisco A, Arifeen SE, et al. Bulging fontanelle after supplementation with 25,000 IU of vitamin A in infancy using immunization contacts. Acta Paediatr 1995; 84: 863-6
39. Kasarskis EJ, Bass NH. Benign intracranial hypertension induced by deficiency of vitamin A during infancy. Neurology 1982; 32: 1292-5
40. Jacobson DM, Berg R, Wall M, et al. Serum vitamin A concentration is elevated in idiopathic intracranial hypertension. Neurology 1999; 53: 1114-8
41. Fishman R. Polar bear liver, vitamin A, aquaporins, and pseudotumor cerebri. Ann Neurol 2002; 52 (5): 531-3
42. Ward A, Brogden RC, Speight TM, et al. Isotretinoin: a review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders. Drugs 1984; 28: 6-37
43. Dicken CH. Retinoids: a review. J Am Acad Dermatol 1884; 11 (4): 541-52
44. Weber D, Dumont E. Pharmacokinetics and pharmacodynamics of 9-cis retinoic acid in healthy men. J Clin Pharmacol 1997; 37: 566-74
45. Bozkurt B, Irkec MT, Atakan N, et al. Lacrimal function and ocular complications in patients treated with systemic isotretinoin. Eur J Ophthalmol 2002: 12 (3): 173-6
46. Fraunfelder FW, Fraunfelder FT, Edwards R. Ocular side effects possibly associated with isotretinoin usage. Am J Ophthalmol 2001; 132 (2): 299-305
47. Bigby M, Stern RS. Adverse reactions to isotretinoin: a report for the Adverse Reaction Reporting System. J Am Acad Dermatol 1988; 18: 543-52
48. Lee AG. Pseudotumor cerebri after treatment with tetracycline and isotretinoin for acne. Cutis 1995; 55: 165-8
49. Spector RH, Carlisle J. Pseudotumor cerebri caused by a synthetic vitamin A preparation. Neurology 1984; 34: 1509-11
50. Fraunfelder FW, Fraunfelder FT, Corbett JJ. Isotretinoin-associated intracranial hypertension. Ophthalmology 2004; 111: 1248-50
51. Saurat JH, editor. Retinoids: new trends in research and therapy. Basel: Karger, 1985
52. Viraben R, Mathieu C, Fontan B. Benign intracranial hypertension during etretinate therapy for mycosis fungoides. J Am Acad Dermatol 1985; 13 (3): 515-7
53. Bonnetblanc JM, Hugon J, Dumas M, et al. Intracranial hypertension with etretinate [letter]. Lancet 1983; II (8356): 974
54. Chen HY, Tsai RK, Huang SM. ATRA-induced pseudotumor cerebri: one case report. Keohsiung J Med Sci 1998; 14 (1): 58-60
55. Tiamkao S, Sirijirachai C. Pseudotumor cerebri caused by all-trans-retinoic acid. J Med Assoc Thail 2000; 83 (11): 1420-3
56. Naderi S, Nakula S, Marruenda F. et al. Pseudotumor cerebri in acute promyelocytic leukemia: improvement despite ATRA therapy. Ann Hematol 1999; 78 (7): 333-4
57. Sacchi S, Kantarjian HM, Freireich EJ, et al. Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia. Leuk Lymphoma 1999; 35 (5-6): 483-9
58. Sano F, Tsuji K, Kunika N, et al. Pseudotumor cerebri in a patient with acute promyelocytic leukemia during treatment with all-trans retinoic acid. Intern Med 1998; 37 (6): 546-9
59. Decaudin D, Adams D, Naccache P, et al. Maintained all-trans retinoic acid therapy with pseudotumor cerebri despite aggravated symptoms. Leuk Lymphoma 1997; 27 (3-4): 373-4
60. Roytman M, Frumkin A, Boyn TG. Pseudotumor cerebri caused by isotretinoin. Cutis 1988; 42: 399-400
61. Tallman MS, Andersen JW, Schiffer CA, et al. Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. Blood 2000; 95(1): 90-5
62. Goodman LS, Gilman AG, Rail TW. et al. Antimicrobial agents. In: Sande MM, GL, editors. Goodman and Oilman's the pharmacological basis of therapeutics. 8th ed. Elmsford: Pergamon Press (NY), 1990: 1117-25
63. Jain A, Sangal L, Basa E, et al. Anti-inflammatory effects of erythromycin and tetracycline on Propionibacterium acnes induced production of chemotactic factors and reactive oxygen species by human neutrophils. Dermatol Online J 2002; 8 (2): 2
64. Ingraham E. The effects of tetracyclines and erythromycin on complement activation in vitro. Acta Derm Venereol 1990; 70 (6): 531-4
65. Minutello JS, Dimayuga RG, Carter J. Pseudotumor cerebri, a rare adverse reaction to tetracycline therapy. J Periodomol 1988; 58: 848-51
66. Maroon JC, Mealy Jr J. Benign intracranial hypertension: sequel to tetracycline therapy in a child. JAMA 1971; 216 (9): 1479-80
67. Gardner K, Cox T, Digre K. Idiopathic intracranial hypertension associated with tetracycline use in fraternal twins: case report and review. Neurology 1995; 45: 6-10
68. Quinn AG, Singer SB, Buncic JR. Pediatric tetracycline-induced pseudotumor cerebri. J AAPOS 1999; 3 (1): 53-7
69. Ohlrich GD, Ohlrich JG. Papilloedema in an adolescent due to tetracycline. Med J Aust 1977; 1: 334-5
70. Pierog SH, Al-Salihi FL, Cinotti D. Pseudotumor cerebri: a complication of tetracycline treatment of acne. J Adolesc Health Care 1986; 7: 139-40
71. Stuart BH, Litt IF. Tetracycline-induced intracranial hypertension in an adolescent: a complication of systemic acne therapy. J Pediatr 1978; 92 (4): 679-80
72. Pearson MG, Littlewood SM, Bowden AN. Tetracycline and benign intracranial hypertension. BMJ 1981; 282: 568-9
73. Koch-Weser J, Gilmore EB. Benign intracranial hypertension in an adult after tetracycline therapy. JAMA 1967; 200 (4): 169-71
74. Giles CL, Soble AR. Intracranial hypertension and tetracycline therapy. Am J Ophthalmol 1971; 72: 981-2
75. Dhiravibulya K, Ouvrier R, Johnston I, et al. Benign intracranial hypertension in childhood; a review of 23 patients. J Paediatr Child Health 1991; 27: 204-7
76. Meacock DJ, Hewer RL. Tetracycline and benign intracranial hypertension. BMJ 1981; 282: 1240
77. Moskowitz T, Leibowitz E, Ronen M, et al. Pseudotumor cerebri induced by vitamin A combined with minocycline. Ann Ophthalmol 1993; 25: 306-8
78. Chiu AM, Chuenkongkaew WL, Cornblath WT, et al. Minocycline treatment and pseudotumor cerebri syndrome. Am J Ophthalmol 1998; 126: 116-21
79. Donnet A, Dufour H, Graziani N, et al. Minocycline and benign intracranial hypertension. Biomed Pharmacother 1992; 46: 171-2
80. Beran RG. Pseudotumor cerebri associated with minocycline therapy for acne. Med J Aust 1980; 1: 323-4
81. Lochhead J, Elston JS. Doxycycline induced intracranial hypertension. BMJ 2003; 326: 641-2
82. Granholm L. Papilloedema in treatment with doxycycline. Lakartidningen 1976; 73: 3447
83. Friedman DI, Gordon LK, Egan RA, et al. Doxycycline and intracranial hypertension. Neurology 2004; 62: 2297-9
84. Neville BGR, Wilson J. Benign intracranial hypertension following corticosteroid withdrawal in childhood. BMJ 1970; 3: 554-6
85. Liu GT, Kay MD, Bienfang DC, et al. Pseudotumor cerebri associated with corticosteroid withdrawal in inflammatory bowel disease. Am J Ophthalmol 1994; 117: 352-7
86. Levine A, Watemberg N, Hager H, et al. Benign intracranial hypertension associated with budesonide treatment in children with Crohn's disease. J Child Neurol 2001; 16: 458-61
87. Alder J, Fraunfelder F, Edwards R, et al. Levonorgestrel implants and intracranial hypertension. N Engl J Med 1995; 332 (25): 1720-1
88. Ruiz-Maldonado R, Tamayo-Sanchez L, de La Luz Orozco-Covarrubias M. The use of retinoids in the pediatric patients. Dermatol Clin 1998; 16 (3): 553-69
89. Wysowski DK, Green L. Serious adverse events in Norplant users reported to the Food and Drug Administration's MedWatch spontaneous reporting system. Obstet Gynecol 1995; 85: 538-42